Difference between revisions of "Team:CGU Taiwan/Results"

Line 38: Line 38:
 
}
 
}
 
.mid {
 
.mid {
   left: 150px;
+
   left: 250px;
 
   width: 700px;
 
   width: 700px;
 
   height: 5000px;
 
   height: 5000px;
Line 311: Line 311:
 
<h1 style="font-size:40px;color:#140731;text-decoration:none;top:10px;">Results</h1><br>
 
<h1 style="font-size:40px;color:#140731;text-decoration:none;top:10px;">Results</h1><br>
  
<ul style="list-style-type: circle;color:#FF8800;font-size:18px;">
 
 
<a href="#anchor1" style="text-decoration:none;color:#FF8800;">Shuttle vector-Leishmania antigen expression system</a>
 
<a href="#anchor1" style="text-decoration:none;color:#FF8800;">Shuttle vector-Leishmania antigen expression system</a>
 
<a href="#anchor2" style="text-decoration:none;color:#FF8800;">Leijuvant-the immune response of photo-inactivated leishmania as adjuvant in mice</a>
 
<a href="#anchor2" style="text-decoration:none;color:#FF8800;">Leijuvant-the immune response of photo-inactivated leishmania as adjuvant in mice</a>
 
<a href="#anchor3" style="text-decoration:none;color:#FF8800;">Prediction-Dendritic cell MHC peptide presentation</a>
 
<a href="#anchor3" style="text-decoration:none;color:#FF8800;">Prediction-Dendritic cell MHC peptide presentation</a>
</ul>
 
 
   
 
   
  

Revision as of 20:51, 19 October 2016

Leijuvant